NM_000069.3:c.1995C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000069.3(CACNA1S):​c.1995C>T​(p.Ala665Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00443 in 1,613,926 control chromosomes in the GnomAD database, including 191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A665A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.019 ( 97 hom., cov: 34)
Exomes 𝑓: 0.0030 ( 94 hom. )

Consequence

CACNA1S
NM_000069.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -5.01

Publications

1 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital myopathy 18
    Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myopathy
    Inheritance: SD, AD, AR Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 1-201074574-G-A is Benign according to our data. Variant chr1-201074574-G-A is described in ClinVar as Benign. ClinVar VariationId is 254809.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0588 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.1995C>Tp.Ala665Ala
synonymous
Exon 14 of 44NP_000060.2Q13698

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.1995C>Tp.Ala665Ala
synonymous
Exon 14 of 44ENSP00000355192.3Q13698
CACNA1S
ENST00000367338.7
TSL:5
c.1995C>Tp.Ala665Ala
synonymous
Exon 14 of 43ENSP00000356307.3B1ALM3
CACNA1S
ENST00000681874.1
c.1995C>Tp.Ala665Ala
synonymous
Exon 14 of 43ENSP00000505162.1A0A7P0T8M7

Frequencies

GnomAD3 genomes
AF:
0.0186
AC:
2830
AN:
152174
Hom.:
97
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0609
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00621
Gnomad ASJ
AF:
0.0409
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.00657
AC:
1649
AN:
251148
AF XY:
0.00529
show subpopulations
Gnomad AFR exome
AF:
0.0606
Gnomad AMR exome
AF:
0.00362
Gnomad ASJ exome
AF:
0.0419
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000669
Gnomad OTH exome
AF:
0.00701
GnomAD4 exome
AF:
0.00295
AC:
4315
AN:
1461634
Hom.:
94
Cov.:
31
AF XY:
0.00271
AC XY:
1973
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.0658
AC:
2203
AN:
33472
American (AMR)
AF:
0.00436
AC:
195
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0415
AC:
1083
AN:
26118
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86200
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53412
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5766
European-Non Finnish (NFE)
AF:
0.000367
AC:
408
AN:
1111876
Other (OTH)
AF:
0.00669
AC:
404
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
246
493
739
986
1232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0186
AC:
2831
AN:
152292
Hom.:
97
Cov.:
34
AF XY:
0.0178
AC XY:
1327
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0608
AC:
2525
AN:
41552
American (AMR)
AF:
0.00621
AC:
95
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0409
AC:
142
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000485
AC:
33
AN:
68018
Other (OTH)
AF:
0.0147
AC:
31
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
144
288
433
577
721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0132
Hom.:
34
Bravo
AF:
0.0214
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.00113

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Malignant hyperthermia, susceptibility to, 5 (3)
-
-
2
Hypokalemic periodic paralysis, type 1 (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Congenital myopathy 18 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)
-
-
1
Thyrotoxic periodic paralysis, susceptibility to, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
1.8
DANN
Benign
0.71
PhyloP100
-5.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16847664; hg19: chr1-201043702; API